Strain SummaryHR Hrhr/+
Strain Name |
HR Hrhr/+ |
Strain Type(s) |
spontaneous mutation |
Strain Synonym(s) |
haired • HR • HR haired • HR hr/+ |
Description |
Heterozygous mice - "hairless" mutation |
Strain Links |
• Festing's List of Inbred Strains |
Strain Genetics |
Hrhr / Hr+ |
Frequency | ||||||||
---|---|---|---|---|---|---|---|---|
Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
Blood vessel hemangioendothelioma | Blood vessel | 4-o-tolylazo-o-toluidine (2-amino-5-azotoluene) |
71 |
65 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||
Blood vessel hemangioendothelioma | Blood vessel |
26 |
33 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
||||
Connective tissue - Fibroblast fibrosarcoma | Connective tissue - Fibroblast | 4-o-tolylazo-o-toluidine (2-amino-5-azotoluene) |
8.7 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
||||
Connective tissue - Fibroblast fibrosarcoma | Connective tissue - Fibroblast |
8.7 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||||
Eye - Harderian gland tumor | Eye - Harderian gland | 4-o-tolylazo-o-toluidine (2-amino-5-azotoluene) |
3.2 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
||||
Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte | 4-o-tolylazo-o-toluidine (2-amino-5-azotoluene) |
3.2 |
4.3 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||
Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
4.3 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||||
Leukocyte - Lymphocyte reticulum cell neoplasm, type A | Leukocyte - Lymphocyte | 4-o-tolylazo-o-toluidine (2-amino-5-azotoluene) |
6.5 |
8.7 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||
Leukocyte - Lymphocyte reticulum cell neoplasm, type A | Leukocyte - Lymphocyte |
8.7 |
8.3 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
||||
Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
13 |
4.2 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
||||
Liver hepatoma | Liver | 4-o-tolylazo-o-toluidine (2-amino-5-azotoluene) |
81 |
39 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||
Liver hepatoma | Liver |
4.3 |
21 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
||||
Lung squamous cell carcinoma | Lung |
4.2 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||||
Lung tumor | Lung | 4-o-tolylazo-o-toluidine (2-amino-5-azotoluene) |
9.7 |
13 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||
Lung tumor | Lung |
17 |
12.5 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
||||
Mammary gland adenoacanthoma | Mammary gland |
4.3 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||||
Mammary gland adenocarcinoma - type A | Mammary gland |
4.3 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||||
Ovary - Granulosa cell tumor | Ovary - Granulosa cell | 4-o-tolylazo-o-toluidine (2-amino-5-azotoluene) |
16 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
||||
Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
8.7 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||||
Ovary tumor - papillary cystic | Ovary |
4.3 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||||
Skin carcinoma | Skin | methylcholanthrene (MCA) |
high |
References: Heston WE, 1963;():247-68 |
||||
Skin papilloma | Skin | 4-o-tolylazo-o-toluidine (2-amino-5-azotoluene) |
3.2 |
4.3 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||
Skin papilloma | Skin |
4.2 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |
|||||
Skin papilloma | Skin | methylcholanthrene (MCA) |
100 |
References: Heston WE, 1963;():247-68 |
||||
Stomach - Glandular - Pyloric antrum papilloma | Stomach - Glandular - Pyloric antrum |
4.2 |
References: Deringer MK, J Natl Cancer Inst 1956;17(4):533-9 |